Guided Solutions’ Post

Hello, professionals! Discover how AI-driven stethoscopes like the Mintti Smartho-D2 are transforming cardiac diagnostics and improving patient outcomes. This article explores the evolution of stethoscope technology and the future of intelligent monitoring in healthcare. Join the conversation on advancing medical innovation!Read more at https://lnkd.in/g65AY3AF #AIinHealthcare #CardiacCare #HealthTech #Minttihealth #MedicalInnovation #PatientOutcomes #DigitalHealth

Hello, professionals! Discover how AI-driven stethoscopes like the Mintti Smartho-D2 are transforming cardiac diagnostics and improving patient outcomes. This article explores the evolution of stethoscope technology and the future of intelligent monitoring in healthcare. Join the conversation on advancing medical innovation!Read more at https://lnkd.in/g65AY3AF #AIinHealthcare #CardiacCare #HealthTech #Minttihealth #MedicalInnovation #PatientOutcomes #DigitalHealth

💡 Robert Herman, MD took the stage at #AHA2024 to share exciting advancements in AI-powered cardiac care. In his presentation, "Deep-learning Assisted ECG-based Emergent Cathlab Activation: First Prospective Implementation of a Smartphone-based System," Dr. Herman highlighted our innovative AI solution that optimizes emergency pathways for chest pain patients. The AI-powered ECG model achieved an impressive 95.7% sensitivity in detecting OMI, significantly outperforming standard ECG machines at 47.8%. This technology has a potential to enhance ACS outcomes by improving acute coronary occlusion detection while reducing unnecessary cath lab activations. Dr. Herman also presented findings from "AI-powered Smartphone Application for Detecting Left Ventricular Systolic Dysfunction Using 12-lead ECG." This study showcased how the smartphone-integrated AI reliably detects reduced LVEF, with the potential to streamline patient pathways for echocardiographic evaluation and timely management. 🩺 We’re proud to contribute to advancing real-world clinical outcomes and improving patient care. Stay tuned for a more thorough breakdown on these impactful studies! #CardiologyAI #PowerfulMedical

𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗜𝗻𝘃𝗮𝘀𝗶𝘃𝗲 𝗛𝗲𝗺𝗼𝗱𝘆𝗻𝗮𝗺𝗶𝗰𝘀: 𝗔 𝗡𝗲𝘄 𝗘𝗿𝗮 𝗶𝗻 𝗛𝗲𝗮𝗿𝘁 𝗙𝘂𝗻𝗰𝘁𝗶𝗼𝗻 𝗔𝘀𝘀𝗲𝘀𝘀𝗺𝗲𝗻𝘁 Since the breakthrough discovery of blood circulation in 1628, haemodynamics has continuously evolved. Fast forward to 1984—the introduction of the 𝗰𝗼𝗻𝗱𝘂𝗰𝘁𝗮𝗻𝗰𝗲 𝗰𝗮𝘁𝗵𝗲𝘁𝗲𝗿 revolutionized how we understand pressure-volume (PV) relationships. These advancements aren't just academic milestones. Today, 𝗰𝗮𝗿𝗱𝗶𝗮𝗰 𝗰𝗮𝘁𝗵𝗲𝘁𝗲𝗿𝗶𝘇𝗮𝘁𝗶𝗼𝗻 and load-independent PV manoeuvres are 𝘁𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗶𝗻𝗴 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗱𝗲𝗰𝗶𝘀𝗶𝗼𝗻-𝗺𝗮𝗸𝗶𝗻𝗴, offering precise assessments for heart failure and optimizing patient care. 𝗪𝗵𝘆 𝗜𝘁 𝗠𝗮𝘁𝘁𝗲𝗿𝘀: ▪ Load-independent indices provide objective measurements of heart function. ▪ These tools empower clinicians to detect heart failure earlier and make evidence-based decisions. Explore Filip Konecny insights how these innovations are shaping the future of 𝗰𝗮𝗿𝗱𝗶𝗮𝗰 𝗰𝗮𝗿𝗲 𝗮𝗻𝗱 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵. 👇 𝗙𝗼𝗿 𝗰𝗼𝗺𝗽𝗿𝗲𝗵𝗲𝗻𝘀𝗶𝘃𝗲 𝗘-𝗯𝗼𝗼𝗸: https://lnkd.in/d88B3hy 𝗙𝗼𝗿 𝗢𝗻𝗹𝗶𝗻𝗲 𝘀𝗼𝘂𝗿𝗰𝗲: https://lnkd.in/g8JwxybZ #Cardiology #Hemodynamics #HeartHealth #MedicalInnovation #HealthcareProfessionals

Heart failure has come to the fore as an innovation and acquisition target for medical device companies at a time when the Heart Failure Society of America is working to create guidelines that support the use of devices in many groups of heart failure patients. The challenge remains: characterizing patients and understanding the best approach for them. We are excited to share a new in-depth feature article "Devices for Many-Faceted Heart Failure" by Mary Stuart, now live on the comprehensive MyStrategist.com platform. Heart failure is a complex condition, demanding diverse approaches and cutting-edge solutions. Our feature provides a comprehensive look at key innovations in this space: https://bit.ly/48tqK3C Explore the main article along with these three companion articles: 1️⃣ "Acorai Serves Up Long-Desired Noninvasive Pulmonary and Cardiac Pressure Sensing:" Acorai has developed a new sensor called SAVE for noninvasively measuring cardiac and pulmonary pressures with high accuracy. SAVE is a combination of four sensors innovatively adapted from other industries, the output of which is enabled by machine learning: https://bit.ly/48qpMoR 2️⃣ "Adona Medical: An Individualized Approach to Interatrial Shunting:" Adona Medical is already working on the next generation of interatrial shunts for heart failure. It's three-pronged advancement in innovation will include the ability to adjust the shunt after implantation, the frequent and automated gathering of data about heart pressures, and a data analytic platform with the ability to inform patient care and the development of future therapies for heart failure: https://bit.ly/3YJ39ss 3️⃣ "CorInnova, Inc.: A Versatile Device Serves Many Heart Failure Patients:" CorInnova, Inc.'s thin-film device is able to deliver active cardiac compressions without contacting blood. opening treatment to hundreds of thousands of heart failure patients without good options: https://bit.ly/3YxoKUY Together, these articles offer insights into groundbreaking advancements designed to transform heart failure treatment. #HeartFailure #MedicalDevices #HealthcareInnovation #Cardiology #MedTech

**Don't Forget To Register For Our Live Webinar taking place this evening** The Impact of Wide Field Imaging for Patient Management - 18th April 5pm (GMT) / 7 pm (CEST) / 1 pm (EDT) Wide field imaging is becoming the standard in retinal imaging for various pathologies. What impact does this have on patient management? Are we discovering more than before? Are we managing patients differently? Register your place here: https://lnkd.in/emnpfa4V #OCT #widefieldimaging #patientmanagement #eyecare

The #AtrialFibrillationDevices Market is poised for significant growth in 2024, driven by technological advancements and a rising patient population. Innovations in cardiac monitoring, catheter ablation, and implantable devices are enhancing patient outcomes while minimizing complications. As healthcare providers focus on improving the quality of care and managing costs, the demand for effective AFib solutions will only escalate. This report delves into market dynamics, key players, and trends shaping the future of atrial fibrillation management. Stay informed to leverage opportunities in this vital sector! #HealthcareInnovation #DigitalHealth #Cardiology #AtrialFibrillation #HeartHealth #MedicalDevices #HealthTech #PatientCare #MarketResearch #ChronicDiseaseManagement #Telemedicine #HealthcareQuality #WearableTechnology #AIinHealthcare #HealthData #ClinicalResearch #PatientEngagement #RegulatoryAffairs #CardiacCare #HealthOutcomes #AtrialFibrillationDevices #CardiacMonitoring #HeartRhythm #CatheterAblation #ImplantableDevices #CardiacRehabilitation #Arrhythmia #Electrophysiology #MarketTrends #HealthcareTechnology #PatientMonitoring #CardiacDeviceMarket #HeartFailure #HealthcareSolutions #ClinicalOutcomes #HealthcareAnalytics #MedicalResearch #DeviceRegulation #HealthEconomics #InnovativeTherapies #PatientSafety Know More : https://lnkd.in/gH3t-gqY

#ICYMI: Heart failure has come to the fore as an innovation and acquisition target for medical device companies at a time when the Heart Failure Society of America is working to create guidelines that support the use of devices in many groups of heart failure patients. The challenge remains: characterizing patients and understanding the best approach for them. Heart failure is a complex condition, demanding diverse approaches and cutting-edge solutions. Our feature provides a comprehensive look at key innovations in this space: https://bit.ly/48tqK3C Read this main article along with these three companion articles: 1️⃣ "Acorai Introduces Noninvasive Pulmonary and Cardiac Pressure Sensing Technology": Acorai has developed a novel sensor called SAVE, which offers precise, noninvasive measurements of cardiac and pulmonary pressures. This device combines four sensors originally designed for other sectors, enhanced by machine learning capabilities: https://bit.ly/48qpMoR 2️⃣ "Adona Medical: Personalized Innovation in Interatrial Shunting": Adona Medical is advancing interatrial shunt technology for heart failure with next-gen features, including adjustable shunts post-implantation, continuous automated data collection on heart pressures, and an analytics platform that supports patient care and guides new therapy developments: https://bit.ly/3YJ39ss 3️⃣ "CorInnova, Inc.: Expanding Heart Failure Treatment Options with a Flexible Device": CorInnova, Inc. has created a thin-film device that delivers cardiac compressions without blood contact, potentially helping hundreds of thousands of heart failure patients lacking effective treatment options: https://bit.ly/3YxoKUY Source of infographic: Heart Failure Society of America #heartfailure #medtech #medtechinnovation #heartcare #cardiaccare #cardiology #medicaldevices #innovation

TAVR and SAVR are associated with comparable long-term outcomes among low-risk patients with severe aortic stenosis (AS). The study compared a group of 1,3000 TAVR patients with more than 1,200 SAVR patients. The average age was 75.5 years old and 62.9% were men. Overall, the group confirmed that TAVR was non-inferior to SAVR when it came to all-cause death, cardiovascular death, myocardial infarction, aortic valve reintervention, endocarditis and bioprosthetic valve failure. There were a couple key differences to consider. TAVR was linked to a heightened risk of permanent pacemaker implantation, and SAVR was linked to more cases of new-onset atrial fibrillation. House all cardiology imaging in one intelligent #CVIS platform with PICOM365 Cloud. Visit our website to learn more. https://hubs.la/Q02Pk1YS0 #TAVR #SAVR #Cardiology

🎓 Exciting Speaker Alert! Dr. Mohammed Shurrab at the International Arrhythmia School! 🎓 We are thrilled to have Dr. Mohammed Shurrab joining us at the International Arrhythmia School, where he will be speaking on Indications for Monitoring Holter and Device Choices. 🩺💡 With his expert insights, Dr. Shurrab will dive deep into the essential factors in selecting the right monitoring strategy and devices—critical knowledge for anyone working with arrhythmia patients. Whether you’re considering Holter monitoring or advanced devices, this session will provide you with the tools to make informed clinical decisions. 🔴 Reminder: This is the FINAL week to register for the lower price! 🔴 🖱️ Sign up today: www.winterarrhytmia.com Don’t miss this opportunity to learn from Dr. Shurrab and other leading experts in the field of arrhythmias! #Arrhythmia #HolterMonitoring #DeviceChoices #DrMohammedShurrab #Cardiology #InternationalArrhythmiaSchool #MedicalEducation #HealthcareProfessionals #RegisterToday #LastChance